ASN Policy Priorities

The American Society of Nephrology (ASN) organized the fourth Kidney Community Advocacy Day (KCAD) on Capitol Hill in Washington, DC, bringing together 13 organizations in the kidney community to raise the profile of kidney diseases with lawmakers.

KidneyX_logo_0.PNGIn coordination with the University of Washington, Northwest Kidney Centers, and the U.S. Department of Health and Human Services (HHS), the American Society of Nephrology (ASN) hosted a listening session for KidneyX on Wednesday, August 22 in Seattle, WA.

On Monday, April 23, the American Society of Nephrology and a record-setting coalition of 36 other organizations in the kidney community, authored a letter to the leadership of the House and Senate Appropriations Subcommittees that appropriate funds for the National Institutes of Health (NIH).

Advocates from the American Society of Nephrology (ASN) and the American Association of Kidney Patients (AAKP) met with representatives, senators, and their respective staffs on March 28, 2018 to urge Congress to support KidneyX, a new public-private partnership to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.

KidneyX will be a public-private partnership to incentivize accelerated development and commercialization of disruptive technologies to reduce the number of patients with ESRD and improve the experience of patients on dialysis.

“The 2018 MACRA proposed rule was the first draft with Price’s involvement after he emphasized that he wanted to reduce reporting burdens and allow clinicians to focus on patient care. His rhetoric proved true as the proposed rule excluded more clinicians from having to participate while also making it easier to avoid a penalty.

Now that he is gone, what will happen to the final rule that is set to be released in November 2017?

How will clinicians plan for 2018… without a solid MACRA rule in place?

American Society of Nephrology (ASN) President Eleanor D. Lederer, MD, FASN, wrote to Senate Majority Leader Mitch McConnell (R-KY) and Minority Leader Charles E. Schumer (D-NY) today expressing ASN’s strong objections to the Graham-Cassidy health care proposal under consideration in the US Senate this week.

Investing in kidney research is crucial to improving clinical outcomes of Americans with kidney disease and the cost-effectiveness of kidney care.

Please bolster kidney research funding by an additional $1.5 billion ($150 million over 10 years) for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH).

Every day ASN volunteers and staff address the most critical issues in healthcare on behalf of patients with kidney disease and the professionals who advance their care. Learn more about issues at the top of ASN's priority list here. These priorities include pushing forward the Living Donor Protection Act, helping legislators understand why more funding for kidney research is vital to improving care, and crafting policies that will improve care of patients with chronic diseases.